Clinical trials
Terminated COVID-19 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 20 |
| 2021 | 19 |
| 2022 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 44 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 2 |
| Hoffmann-La Roche | 2 |
| Abivax S.A. | 1 |
| Acerta Pharma BV | 1 |
| Andrew Eisenberger | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| BioAge Labs, Inc. | 1 |
| BioCryst Pharmaceuticals | 1 |
| Biophytis | 1 |
| Biotest | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 44 |
| Coronavirus Infections | 8 |
| Pneumonia | 3 |
| Cytokine Release Syndrome | 2 |
| Post-Acute COVID-19 Syndrome | 2 |
| Angioedemas, Hereditary | 1 |
| Cardiovascular Diseases | 1 |
| Community-Acquired Pneumonia | 1 |
| Lung Diseases, Interstitial | 1 |
| Lymphopenia | 1 |
Trials
Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.